56
Participants
Start Date
March 31, 2013
Primary Completion Date
November 30, 2021
Study Completion Date
November 30, 2021
Systematic transplantectomy
Transplantectomy within two months after return to dialyse. Antiproliferatives stop at the start of dialysis. Maintenance basic immunosuppressive treatment without dose reduction up to two weeks after transplantectomy. Abrupt discontinuation of the basic immunosuppressive treatment ttwo weeks after transplantectomy. Maintenance corticosteroids at 5mg per day until one month after transplantectomy then stop corticosteroids within one month.
Progressive reduction of immunosuppression
"Progressive reduction of immunosuppression. Transplantectomy for cause only. Antiproliferatives withdrawn at the start of dialysis. Maintenance of anticalcineurin or mTOR inhibitors half dose for 3 months, ¼ dose for 3 months and then stop. Maintenance corticosteroids for 6 months up to 5 mg per day, and then soft stop in 3 months.~In case of transplantectomy by reason in the control group, basic immunosuppression will be continued at the maintenance dose during the current surgical procedure, and withdrawn two weeks later, similary to the strategy used in the study group."
Service de Néphrologie et Transplantation Rénale - Hôpital Lapeyronie, Montpellier
Service de Néphrologie, Immunologie Clinique - CHU Bretonneau, Tours
Service de Néphrologie -Dialyse-Transplantation, Hôpital Michallon, Grenoble
Service de Néphrologie, Dialyse et Transplantation Rénale, Hôpital Nord, Saint-Etienne
Institut de Transplantation, Urologie et Néphrologie - CHU Nantes, Nantes
Service de Néphrologie et Transplantation Rénale, CHU Gabriel Montpied, Clermont-Ferrand
Service de Néphrologie et Transplantation Rénale - Nouvel Hôpital Civil, Strasbourg
Transplantation Department, Hôpital Edourad Herriot, Lyon
Service de Néphrologie-Dialyse, Centre Hospitalier d'Annecy, Pringy
Hospices Civils de Lyon
OTHER